<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01221428</url>
  </required_header>
  <id_info>
    <org_study_id>MSCKJ004</org_study_id>
    <nct_id>NCT01221428</nct_id>
  </id_info>
  <brief_title>Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis</brief_title>
  <official_title>Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qingdao University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qingdao University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of
      treatment for ulcerative colitis is safe and effective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ulcerative colitis is characterized as chronic and nonspecific inflammation of
      gastroenteritis tract．Nowadays，etiology and pathogenesis of UC have been unclear．Recent basic
      research has been revealed that stem cell can settle down in epithelium of gastroenteritis
      tract，which provide a hope for treating the disease.We hope umbilical cord Mesenchymal Stem
      Cells could not only address the need for epithelial cell replacement but also control of the
      autoimmune response to mocous membrane of colon.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the result of enteroscopy and pathological report</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the clinical symptom (including stomachache,abdominal distention,bloody purulent stool)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Mesenchymal Stem Cells</condition>
  <condition>Umbilical Cord</condition>
  <arm_group>
    <arm_group_label>umbilical cord mesenchymal stem cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous infusion of ex vivo cultured umbilical cord mesenchymal stem cells,one week later,conduct intervention operation to inject mesenchymal stem cells to mesenteric artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Umbilical Cord Mesenchymal Stem Cells</intervention_name>
    <description>Intravenous infusion of ex vivo cultured umbilical cord mesenchymal stem cells(2*10/7),one week later,conduct intervention operation to inject mesenchymal stem cells to mesenteric artery(1*10/7).</description>
    <arm_group_label>umbilical cord mesenchymal stem cells</arm_group_label>
    <other_name>Mesenchymal Stem Cells</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, 18 years of age or older.

          -  Ulcerative colitis described according to usual criteria.

          -  Refractoriness Ulcerative colitis or unefficient by using other therapy

          -  Signed informed consent form.

        Exclusion Criteria:

          -  History of neoplasm or hematological disease

          -  Uncontrolled high blood pressure (&gt;180/110)

          -  Severe cardiac insufficiency (New York Heart Association [NYHA] IV) or ejection
             fraction&lt;30%

          -  Malignant ventricular arrythmia

          -  Deep venous thrombosis during the last 3 months

          -  Active bacterial infection

          -  Body mass index &gt; 35 Kg/m2

          -  Stroke or myocardial infarction during the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gang Zhao, MD</last_name>
    <role>Study Director</role>
    <affiliation>The Affiliated Hospital of Medical College of Qingdao University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stem Cell Research Center of Medical School Hospital of Qingdao University</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2010</study_first_posted>
  <last_update_submitted>October 14, 2010</last_update_submitted>
  <last_update_submitted_qc>October 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Wang, Yangang MD</name_title>
    <organization>Stem Cell Research Center of Medical School Hospital of Qingdao University</organization>
  </responsible_party>
  <keyword>Ulcerative colitis</keyword>
  <keyword>Mesenchymal Stem Cells</keyword>
  <keyword>Umbilical Cord</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

